Suwanwongse Kulachanya, Shabarek Nehad
Internal Medicine, Lincoln Medical Center, New York City, USA.
Cureus. 2020 Apr 26;12(4):e7834. doi: 10.7759/cureus.7834.
Appendectomy is the gold standard of treatment for acute appendicitis; however, recent evidence suggests conservative management with intravenous antibiotics may provide similar outcomes and can be used as an alternative in selected patients. Performing appendectomy in acute appendicitis patients with 2019 novel Coronavirus Disease (COVID-19) is challenging, as it involves considerable operative risks for the patients and risks for health care professionals (HCPs) exposed to COVID-19. Medical management eliminates the morbidity and mortality associated with surgery but involves significant risks of treatment failures that, in turn, may lead to perforation, peritonitis, and death. We are reporting a case of a middle-aged man with multiple co-morbidities, who was diagnosed with COVID-19 and acute appendicitis. Our patient received intravenous antibiotics for seven days with a significant improvement in symptoms. Our case report illustrates the implementation of successful conservative treatment for acute appendicitis in COVID-19 patients.
阑尾切除术是治疗急性阑尾炎的金标准；然而，最近的证据表明，静脉使用抗生素进行保守治疗可能会产生相似的结果，并且在特定患者中可作为一种替代方法。对于患有2019年新型冠状病毒病（COVID-19）的急性阑尾炎患者进行阑尾切除术具有挑战性，因为这对患者而言涉及相当大的手术风险，且对接触COVID-19的医护人员（HCPs）也存在风险。药物治疗可消除与手术相关的发病率和死亡率，但存在治疗失败的重大风险，而这反过来可能导致穿孔、腹膜炎和死亡。我们报告了一例患有多种合并症的中年男性病例，该患者被诊断为COVID-19和急性阑尾炎。我们的患者接受了七天的静脉抗生素治疗，症状有显著改善。我们的病例报告说明了对COVID-19患者的急性阑尾炎成功实施保守治疗的情况。
